172 related articles for article (PubMed ID: 32925123)
1. Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction.
Bao H; Gao HR; Pan ML; Zhao L; Sun HB
Technol Health Care; 2021; 29(1):85-90. PubMed ID: 32925123
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Alteplase on Treatment of Acute Single Small Subcortical Infarction.
Marcelinus K; Liu H; Zhang K; Zong C; Yang H; Song B; Gao Y; Xu Y
Curr Neurovasc Res; 2022; 19(3):255-266. PubMed ID: 36043775
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of alteplase intravenous thrombolysis combined with butylphthalide in patients with acute severe cerebral infarction.
Wang Z; Che J
Folia Neuropathol; 2022; 60(4):421-426. PubMed ID: 36734384
[TBL] [Abstract][Full Text] [Related]
4. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction.
Wang J; Fang X; Wang D; Xiao Y
Braz J Med Biol Res; 2021; 54(5):e10000. PubMed ID: 33729386
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction.
Sun F; Liu H; Fu HX; Zhang S; Qian XD; Li JJ; Zhu YB; Zhang XX; Zhang J; Qiu HP; Kang LL; Hu YJ; Zhao L; Mi YJ; Gao YJ; Dou ZJ; Ma Z
J Int Med Res; 2020 May; 48(5):300060519895352. PubMed ID: 32357116
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Clinical Efficacy of Recombinant Tissue Plasminogen Activator on Acute Cerebral Infarction.
Wu T; Li P; Sun D
J Nanosci Nanotechnol; 2020 Dec; 20(12):7781-7786. PubMed ID: 32711658
[TBL] [Abstract][Full Text] [Related]
8. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
[TBL] [Abstract][Full Text] [Related]
9. Rt-PA thrombolytic therapy in patients with acute posterior circulation stroke: A retrospective study.
Hu Y; Zheng H; Chen X; Gao Z
Med Int (Lond); 2022; 2(2):8. PubMed ID: 36699100
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of different doses of alteplase thrombolysis on acute ischemic stroke in patients.
Xu H
Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2465-2469. PubMed ID: 31894036
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety comparison between pro-urokinase and reteplase in the treatment of patients with acute ST elevation myocardial infarction].
Zhang Y; Wang S; Gao CY; Liu XY; Cheng QQ; Zhang JH; Qi DD; Wang XP; Zhu ZY; Li MW; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Sep; 49(9):866-872. PubMed ID: 34530593
[No Abstract] [Full Text] [Related]
12. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
[TBL] [Abstract][Full Text] [Related]
13. Transcranial Pulsed Ultrasound with Alteplase Intravenous Thrombolysis for Vascular Recanalisation in Acute Ischemic Stroke.
Chen Z; Zhang J
J Coll Physicians Surg Pak; 2020 Jul; 30(7):765-767. PubMed ID: 32811613
[TBL] [Abstract][Full Text] [Related]
14. [The factors predicting early efficacy of intravenous thrombolysis with alteplase in acute ischemic stroke].
Song YP; Li YS
Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):781-3. PubMed ID: 23290976
[TBL] [Abstract][Full Text] [Related]
15. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous thrombolysis with alteplase combined with edaravone on cerebral hemodynamics and T lymphocyte level in patients with acute cerebral infarction.
Li XX; Liu SH; Zhuang SJ; Guo SF; Pang SL
Medicine (Baltimore); 2020 Dec; 99(50):e23414. PubMed ID: 33327266
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety assessment of alteplase in the treatment of stroke - gender differences.
Lasek-Bal A; Puz P; Kazibutowska Z
Neurol Res; 2014 Sep; 36(9):851-6. PubMed ID: 24620981
[TBL] [Abstract][Full Text] [Related]
18. [Effect of intravenous thrombolysis with recombinant tissue type plasminogen activator (rt-PA) in different time windows on acute cerebral infarction patients with atrial fibrillation].
Guo Y; Zhang CH; Wang HY; Lin YN; Wang Y; Sun XP
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2054-8. PubMed ID: 27468616
[TBL] [Abstract][Full Text] [Related]
19. [Application of quantitative electroencephalogram monitoring in evaluating thrombolytic effect of acute cerebral infarction].
Jin L; Wang Y; Lyu Z; Zhang C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):207-210. PubMed ID: 33729141
[TBL] [Abstract][Full Text] [Related]
20. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
